Primary Biliary Cholangitis and Primary Sclerosing Cholangitis are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.
Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis at a glance
Primary Biliary Cholangitis: Autoimmune destruction of small intrahepatic bile ducts → cholestasis, pruritus, fatigue; AMA-positive in 95%.
Primary Sclerosing Cholangitis: Chronic fibroinflammatory disease of intra- and extrahepatic bile ducts → strictures and biliary cirrhosis; strong IBD link.
Try two board-style questions on Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1GastrointestinalMedium
A 54-year-old woman with primary biliary cholangitis diagnosed 6 years ago has been maintained on ursodeoxycholic acid with a good biochemical response. She reports persistent fatigue and intermittent nocturnal pruritus but feels otherwise well. Her examination shows xanthelasmas and mild hepatomegaly without jaundice or ascites. Alkaline phosphatase is mildly elevated, bilirubin and albumin are normal, and abdominal ultrasound shows no biliary dilation. Which of the following complications is she most likely to develop over the course of her disease?
AOsteoporosis with fragility fractures
BAscending cholangitis with biliary stones
CCholangiocarcinoma from ductal strictures
DPancreatic insufficiency with steatorrhea
Reveal answer & full explanation
Correct answer: A — Osteoporosis with fragility fractures
AOsteoporosis with fragility fractures✓
BAscending cholangitis with biliary stones
CCholangiocarcinoma from ductal strictures
DPancreatic insufficiency with steatorrhea
Why Osteoporosis with fragility fractures is correct
PBC carries the highest osteoporosis risk of any chronic liver disease; chronic cholestasis impairs bone formation and reduces fat-soluble vitamin D absorption, accelerating bone loss in an already high-risk middle-aged/postmenopausal female population.
Guidelines recommend baseline and serial DEXA (about every 2 years) with calcium and vitamin D supplementation for all PBC patients, reflecting how expected this complication is even in well-controlled disease.
Why the others are wrong
Cholangiocarcinoma from ductal strictures is the feared malignancy of primary sclerosing cholangitis, which produces intra- and extrahepatic strictures; PBC targets small interlobular ducts, has a normal MRCP, and its main malignancy risk is hepatocellular carcinoma in cirrhotic patients, not cholangiocarcinoma.
Pancreatic insufficiency with steatorrhea reflects chronic pancreatitis or cystic fibrosis; any malabsorption in PBC stems from cholestatic bile-acid deficiency and fat-soluble vitamin loss, not absent pancreatic enzymes.
Ascending cholangitis with biliary stones arises from mechanical extrahepatic obstruction; PBC is a noninfectious small-duct autoimmune process with a patent biliary tree and normal ultrasound, so bacterial cholangitis is not characteristic.
Question 2GastrointestinalEasy
A 35-year-old man with ulcerative colitis reports several months of fatigue and pruritus. Laboratory studies show an alkaline phosphatase of 420 U/L and a GGT of 380 U/L with near-normal aminotransferases. Magnetic resonance cholangiopancreatography shows multifocal strictures and dilations producing a beaded appearance of the intra- and extrahepatic bile ducts. Which of the following is the most likely diagnosis?
ACholedocholithiasis
BPrimary biliary cholangitis
CPrimary sclerosing cholangitis
DAutoimmune hepatitis
Reveal answer & full explanation
Correct answer: C — Primary sclerosing cholangitis
ACholedocholithiasis
BPrimary biliary cholangitis
CPrimary sclerosing cholangitis✓
DAutoimmune hepatitis
Why Primary sclerosing cholangitis is correct
A cholestatic pattern (elevated alkaline phosphatase and GGT with near-normal aminotransferases) in a patient with ulcerative colitis points to primary sclerosing cholangitis
PSC is a fibro-inflammatory disorder that strictures both the intra- and extrahepatic ducts, and more than 70% of patients have inflammatory bowel disease, usually ulcerative colitis
MRCP characteristically shows alternating strictures and dilations producing the classic beaded appearance; PSC also carries a long-term risk of cholangiocarcinoma
Why the others are wrong
Choledocholithiasis - a common bile duct stone produces focal obstruction with upstream dilation, not diffuse multifocal beading of both intra- and extrahepatic ducts (confused-with-obstructive-stone)
Primary biliary cholangitis - targets small intrahepatic ducts in middle-aged women, is antimitochondrial-antibody positive, and is not associated with ulcerative colitis or extrahepatic ductal beading (premature closure on the other cholangitis)
Autoimmune hepatitis - a hepatocellular disease with markedly elevated aminotransferases and positive ANA/anti-smooth-muscle antibodies, not a cholestatic ductal disease (buzzword-matching to autoimmune)
🔒 Free preview limit reached
Keep comparing — start your free trial
You've used your 2 free previews. Create your free account to see the full Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.
Autoimmune destruction of small intrahepatic bile ducts → cholestasis, pruritus, fatigue; AMA-positive in 95%.
Chronic fibroinflammatory disease of intra- and extrahepatic bile ducts → strictures and biliary cirrhosis; strong IBD link.
Classic presentation
Middle-aged woman with fatigue, pruritus, and isolated alkaline phosphatase elevation — check AMA.; Often asymptomatic at diagnosis (incidental cholestatic LFT pattern in ~60%); Fatigue (the most common symptom, often disabling); Pruritus (often nocturnal, worsens before jaundice); Right upper quadrant discomfort; Sicca symptoms (dry…
Young man with ulcerative colitis and an elevated alkaline phosphatase — get an MRCP.; Often asymptomatic at diagnosis (~50%) — found via incidental cholestatic LFTs in known IBD; Fatigue, pruritus, right upper quadrant pain; Intermittent jaundice and recurrent bacterial cholangitis (fever, RUQ pain, jaundice — Charcot triad); Weight…
Workup / key labs
2 of 3: (1) cholestatic biochemistry (elevated alkaline phosphatase ≥1.5× ULN >6 months), (2) AMA positive (≥1:40) or PBC-specific ANA, (3) liver biopsy showing nonsuppurative destructive cholangitis with bile duct injury. Biopsy not required if first two are met.; LFTs — cholestatic pattern: elevated alkaline phosphatase and GGT,…
Characteristic MRCP/ERCP findings + cholestatic LFTs + exclusion of secondary causes. Small-duct PSC requires biopsy with cholestatic biochemistry and IBD.; Cholestatic LFTs: elevated alkaline phosphatase, GGT, modest AST/ALT; bilirubin variable, elevates with strictures or cirrhosis; p-ANCA positive in ~70% (atypical perinuclear…
Imaging
Abdominal ultrasound — exclude biliary obstruction; nonspecific for PBC; MRCP — typically normal in PBC (distinguishes from PSC, which shows beading)
Magnetic resonance cholangiopancreatography (MRCP) — first-line diagnostic test; demonstrates multifocal intra- and extrahepatic strictures with alternating dilation ('beaded' appearance); ERCP — therapeutic role for dominant strictures; reserved for intervention or when MRCP nondiagnostic; Liver biopsy — not required for diagnosis if…
First-line treatment
Ursodeoxycholic acid (UDCA) 13-15 mg/kg/day in divided doses — first-line for all PBC patients; improves transplant-free survival; Assess biochemical response at 12 months: e.g., Paris II criteria (ALP and AST ≤1.5× ULN with normal bilirubin); inadequate response → add second-line therapy
No proven disease-modifying medical therapy; Ursodeoxycholic acid (UDCA) — improves biochemistry but no proven survival benefit; high-dose (28-30 mg/kg/day) is harmful (increased adverse events, do NOT use); moderate dose (13-23 mg/kg/day per AASLD 2023; 15-20 mg/kg/day per EASL 2022) may be considered to improve liver tests, but…
Drill Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis questions on FirstPassPA
Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.